
1. General Information
Letfit 2.5 mg Tablet contains Letrozole 2.5 mg, a non-steroidal aromatase inhibitor. Letrozole reduces estrogen production in the body by inhibiting the aromatase enzyme. Lower estrogen levels can help slow or stop the growth of estrogen-dependent breast cancer cells.
It is primarily prescribed for certain types of hormone receptor-positive breast cancer in postmenopausal women. Letrozole is a prescription medicine and should be used under the supervision of a qualified healthcare professional.
2. Product Information
- Product Name: Letfit 2.5 mg Tablet
- Active Ingredient: Letrozole
- Strength: 2.5 mg
- Drug Class: Aromatase inhibitor
- Dosage Form: Oral tablet
- Therapeutic Category: Hormonal/anticancer medicine
- Primary Therapeutic Use: Certain hormone-sensitive breast cancers
- Prescription Status: Prescription medicine
- Common Reference Brand: Femara (letrozole)
The 2.5 mg strength is an established oral dosage form of letrozole.
3. Uses of Letfit 2.5 mg Tablet
Letrozole may be prescribed for:
- Hormone receptor-positive early breast cancer in postmenopausal women
- Extended adjuvant treatment after previous tamoxifen therapy
- Certain locally advanced or metastatic hormone-sensitive breast cancers
- Other clinically appropriate uses determined by a specialist
The exact indication depends on the patient's cancer type, menopausal status, previous treatment and clinical condition.
4. Benefits of Letfit 2.5 mg Tablet
When appropriately prescribed, Letfit 2.5 mg may provide the following therapeutic benefits:
- Helps reduce estrogen production
- Helps control estrogen-dependent breast cancer growth
- Can be used as adjuvant hormonal therapy after primary breast-cancer treatment
- May help reduce the risk of breast-cancer recurrence in appropriate patients
- Provides a convenient once-daily oral treatment option
The benefit of treatment depends on the individual's diagnosis and response to therapy.
5. Side Effects of Letfit 2.5 mg Tablet
Like other medicines, letrozole can cause side effects. Not every patient experiences them, and their severity can vary.
Possible side effects include:
- Hot flushes and sweating
- Joint or muscle pain
- Tiredness
- Headache
- Dizziness
- Nausea
- Reduced appetite
- Mood changes
- Increased cholesterol
- Bone or musculoskeletal discomfort
- Vaginal bleeding in some patients
Long-term treatment can contribute to reduced bone mineral density and increased risk of osteoporosis or fractures, so appropriate monitoring may be recommended.
6. Common Side Effects
Commonly reported effects include:
- Hot flushes
- Increased sweating
- Joint pain
- Muscle or bone pain
- Fatigue
- Headache
- Dizziness
- Nausea
- Mood changes
- Increased cholesterol
If side effects are persistent, severe or concerning, the patient should consult their doctor rather than stopping treatment independently.
7. How to Use Letfit 2.5 mg Tablet
Letfit 2.5 mg should be taken exactly as prescribed by the treating physician.
For letrozole, the commonly recommended adult regimen for approved breast-cancer indications is 2.5 mg once daily, although the appropriate regimen can vary according to the clinical situation. It may be taken with or without food and should generally be taken at approximately the same time each day. Swallow the tablet whole with water.
Do not change the dose, stop treatment, or take additional tablets without medical advice.
8. How Letfit 2.5 mg Works
Letfit 2.5 mg contains letrozole, which blocks the enzyme aromatase.
Aromatase helps convert certain hormones into estrogen. By inhibiting this enzyme, letrozole lowers estrogen production. Since some breast-cancer cells depend on estrogen for growth, reducing estrogen can help slow or stop the growth of these cancer cells.
In simple terms:
Aromatase blocked → estrogen production reduced → estrogen stimulation of susceptible cancer cells reduced.
9. Safety Advice for Letfit 2.5 mg Tablet
- Use only under the supervision of a qualified healthcare professional.
- Inform your doctor about all medicines and supplements you are taking.
- Tell your doctor if you have liver problems, osteoporosis, high cholesterol or other significant medical conditions.
- Bone health may require monitoring during prolonged treatment.
- Blood pressure and cholesterol may also require periodic monitoring.
- Letrozole is generally intended for postmenopausal patients in its principal breast-cancer indications; pregnancy is a contraindication for approved breast-cancer use.
- If you experience significant dizziness, fatigue or blurred vision, avoid driving or operating machinery until you feel well enough.
- Do not stop long-term treatment without discussing it with your healthcare professional.
- Seek medical attention for severe allergic reactions or other serious/unusual symptoms.
Important: This information is for general educational and product-description purposes and does not replace a doctor's prescription or medical advice.
10. Frequently Asked Questions (FAQs)
Q1. What is Letfit 2.5 mg Tablet?
Letfit 2.5 mg Tablet contains Letrozole 2.5 mg, an aromatase inhibitor primarily used for certain hormone-sensitive breast cancers.
Q2. What is Letfit 2.5 mg used for?
It is primarily used in the treatment and hormonal management of certain types of breast cancer, particularly in postmenopausal women.
Q3. What is the active ingredient in Letfit 2.5 mg?
The active ingredient is Letrozole 2.5 mg.
Q4. How often is letrozole 2.5 mg taken?
For many approved breast-cancer indications, the usual dose is 2.5 mg once daily, but treatment should follow the prescribing doctor's instructions.
Q5. Can Letfit 2.5 mg be taken with food?
Yes. Letrozole can generally be taken with or without food.
Q6. Does Letfit 2.5 mg reduce estrogen?
Yes. Letrozole inhibits aromatase and consequently reduces estrogen production.
Q7. What are the common side effects?
Hot flushes, sweating, tiredness, joint pain, headache, dizziness and nausea are among the commonly reported effects.
Q8. Can letrozole affect bone health?
Yes. Long-term treatment may reduce bone mineral density and increase the risk of osteoporosis and fractures, so doctors may monitor bone health.
Q9. Is Letfit 2.5 mg a prescription medicine?
Yes. Letrozole is a prescription medicine and should be used according to professional medical advice.
Q10. Can I stop Letfit 2.5 mg when I feel better?
Do not stop it without speaking to your doctor. The duration of hormonal treatment is individualized and can be several years for some patients.
11. Substitute for Letfit 2.5 mg Tablet
The appropriate substitute should contain the same active ingredient and strength: Letrozole 2.5 mg, but the specific brand available depends on the country and market.
Possible alternatives may include:
- Generic Letrozole 2.5 mg tablets
- Femara (letrozole)
- Other locally registered Letrozole 2.5 mg brands
Important: Brand substitution should be confirmed by a doctor or pharmacist, particularly for oncology medicines. Do not substitute letrozole with another aromatase inhibitor such as anastrozole or exemestane without medical advice.
12. SEO & B2B Keywords
- Letfit 2.5 mg Tablet
- Letfit 2.5 mg Letrozole
- Letrozole 2.5 mg Tablets
- Letrozole Tablets USP
- Letrozole 2.5 mg supplier India
- Letrozole pharmaceutical exporter India
- Letrozole tablet exporter from Nagpur
- Letfit 2.5 mg wholesale supplier
- Letrozole 2.5 mg bulk supplier
- Letrozole medicine exporter
- Aromatase inhibitor tablets supplier
- Letrozole oncology medicine supplier
- Letrozole breast cancer medicine
- Hormone therapy medicine supplier
- Letrozole 2.5 mg wholesale export
- Pharmaceutical tablets exporter India
- Letrozole 2.5 mg international supplier
- Letrozole tablets B2B supplier
- Letfit 2.5 mg pharmaceutical supplier
- Letrozole medicine wholesale India
- Letrozole tablets export supplier
- Letrozole 2.5 mg procurement
- Oncology medicine exporter Nagpur
- Letrozole tablets for international markets
- Letfit 2.5 mg tablet supplier India
- Generic letrozole pharmaceutical supplier
- Letrozole 2.5 mg export from India
- Letrozole tablets supplier for USA
- Letrozole tablets supplier for UK
- Letrozole tablets supplier for Australia
- Letrozole tablets supplier for Canada
- Letrozole tablets supplier for Singapore
- Letrozole tablets supplier for South Korea
- Letrozole tablets supplier for UAE
- Phoenix Exim Letrozole supplier
Keywords







